Literature DB >> 22415262

HLA-A*01 allele: a risk factor for dengue haemorrhagic fever in Brazil's population.

Sérgio Pereira Monteiro1, Pedro Emmanuel Alvarenga Americano do Brasil, Giselda Maria Kalil Cabello, Rogério Valls de Souza, Patrícia Brasil, Ingebourg Georg, Pedro Hernan Cabello, Liane De Castro.   

Abstract

Severe forms of dengue, such as dengue haemorrhagic fever (DHF) and dengue shock syndrome, are examples of a complex pathogenic mechanism in which the virus, environment and host immune response interact. The influence of the host's genetic predisposition to susceptibility or resistance to infectious diseases has been evidenced in several studies. The association of the human leukocyte antigen gene (HLA) class I alleles with DHF susceptibility or resistance has been reported in ethnically and geographically distinct populations. Due to these ethnic and viral strain differences, associations occur in each population, independently with a specific allele, which most likely explains the associations of several alleles with DHF. As the potential role of HLA alleles in the progression of DHF in Brazilian patients remains unknown, we then identified HLA-A alleles in 67 patients with dengue fever and 42 with DHF from Rio de Janeiro, Brazil, selected from 2002-2008 by the sequence-based typing technique. Statistical analysis revealed an association between the HLA-A*01 allele and DHF [odds ratio (OR) = 2.7, p = 0.01], while analysis of the HLA-A*31 allele (OR = 0.5, p = 0.11) suggested a potential protective role in DHF that should be further investigated. This study provides evidence that HLA class I alleles might be important risk factors for DHF in Brazilian patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415262     DOI: 10.1590/s0074-02762012000200012

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  7 in total

1.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

2.  Original antigenic sin in dengue revisited.

Authors:  Simona Zompi; Eva Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-16       Impact factor: 11.205

Review 3.  Development of Peptide Vaccines in Dengue.

Authors:  Kavita Reginald; Yanqi Chan; Magdalena Plebanski; Chit Laa Poh
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

4.  Socio-demographic inequalities in the clinical characteristics of dengue haemorrhagic fever in the city of Rio de Janeiro, Brazil, 2007-2008.

Authors:  Sheila Moura Pone; Yara Hahr Marques Hökerberg; Patricia Brasil; Cecília Carmen de Araújo Nicolai; Rogério Ferrari; Raquel de Vasconcellos Carvalhaes de Oliveira
Journal:  Epidemiol Infect       Date:  2018-01-17       Impact factor: 4.434

Review 5.  Epidemiological Scenario of Dengue in Brazil.

Authors:  Rafaelle C G Fares; Katia P R Souza; Germán Añez; Maria Rios
Journal:  Biomed Res Int       Date:  2015-08-30       Impact factor: 3.411

6.  Genome-Wide Analysis to Identify HLA Factors Potentially Associated With Severe Dengue.

Authors:  Sudheer Gupta; Ankita Agarwal; Amod Kumar; Debasis Biswas
Journal:  Front Immunol       Date:  2018-04-10       Impact factor: 7.561

Review 7.  Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

Authors:  Lucas Wilken; Guus F Rimmelzwaan
Journal:  Pathogens       Date:  2020-06-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.